These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 1904073)

  • 1. Acetylcholine receptor-reactive T and B cells in myasthenia gravis and controls.
    Link H; Olsson O; Sun J; Wang WZ; Andersson G; Ekre HP; Brenner T; Abramsky O; Olsson T
    J Clin Invest; 1991 Jun; 87(6):2191-6. PubMed ID: 1904073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cell responses to human recombinant acetylcholine receptor-alpha subunit in myasthenia gravis and controls.
    Sun JB; Harcourt G; Wang ZY; Hawke S; Olsson T; Fredrikson S; Link H
    Eur J Immunol; 1992 Jun; 22(6):1553-9. PubMed ID: 1376263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoreactive T and B cells in nervous system diseases.
    Sun JB
    Acta Neurol Scand Suppl; 1993; 142():1-56. PubMed ID: 8382894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Idiotypic and antiidiotypic T and B lymphocytes in myasthenia gravis.
    Yi Q; Lefvert AK
    J Immunol; 1992 Nov; 149(10):3423-6. PubMed ID: 1431116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell reactivity to acetylcholine receptor in rats orally tolerized against experimental autoimmune myasthenia gravis.
    Wang ZY; Qiao J; Melms A; Link H
    Cell Immunol; 1993 Dec; 152(2):394-404. PubMed ID: 8258147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cord blood contains high numbers of autoimmune T cells recognizing multiple myelin proteins and acetylcholine receptor.
    Fredrikson S; Sun JB; Huang WX; Li BL; Olsson T; Link H
    J Immunol; 1993 Aug; 151(4):2217-24. PubMed ID: 8345205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of anti-acetylcholine receptor-alpha antibody in vitro by peripheral blood lymphocytes of patients with myasthenia gravis: role of immunoregulatory T cells and monocytes.
    Ofosu-Appiah W; Mokhtarian F; Shirazian D; Grob D
    J Lab Clin Med; 1994 Aug; 124(2):231-41. PubMed ID: 8051487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of B-cells in experimental myasthenia gravis in mice.
    Wang HB; Li H; He B; Bakheit M; Levi M; Wahren B; Berglöf A; Sandstedt K; Link H; Shi FD
    Biomed Pharmacother; 1999 Jun; 53(5-6):227-33. PubMed ID: 10424244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B-T lymphocyte interactions in experimental autoimmune myasthenia gravis: antigen presentation by rat/mouse hybridoma lines secreting monoclonal antibodies against the nicotinic acetylcholine receptor.
    Zhang YP; Tzartos SJ; Wekerle H
    Eur J Immunol; 1988 Feb; 18(2):211-8. PubMed ID: 2450756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B and T cell involvement in anti-acetylcholine receptor antibody formation in myasthenia gravis.
    Shinomiya N; Yata J
    Clin Exp Immunol; 1981 Nov; 46(2):277-85. PubMed ID: 6978218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mice with IFN-gamma receptor deficiency are less susceptible to experimental autoimmune myasthenia gravis.
    Zhang GX; Xiao BG; Bai XF; van der Meide PH; Orn A; Link H
    J Immunol; 1999 Apr; 162(7):3775-81. PubMed ID: 10201893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human muscle acetylcholine receptor reactive T and B lymphocytes in the peripheral blood of patients with myasthenia gravis.
    Yi Q; Pirskanen R; Lefvert AK
    J Neuroimmunol; 1993 Feb; 42(2):215-22. PubMed ID: 8429105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of interferon-gamma, interleukin-4, and transforming growth factor-beta in rats orally tolerized against experimental autoimmune myasthenia gravis.
    Wang ZY; Link H; Ljungdahl A; Höjeberg B; Link J; He B; Qiao J; Melms A; Olsson T
    Cell Immunol; 1994 Sep; 157(2):353-68. PubMed ID: 7520837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific activation of lymphocytes against acetylcholine receptor in the thymus in myasthenia gravis.
    Fujii Y; Hashimoto J; Monden Y; Ito T; Nakahara K; Kawashima Y
    J Immunol; 1986 Feb; 136(3):887-91. PubMed ID: 2416838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoreactive T and B cells responding to myelin proteolipid protein in multiple sclerosis and controls.
    Sun JB; Olsson T; Wang WZ; Xiao BG; Kostulas V; Fredrikson S; Ekre HP; Link H
    Eur J Immunol; 1991 Jun; 21(6):1461-8. PubMed ID: 1710567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological heterogeneity of autoreactive T lymphocytes against the nicotinic acetylcholine receptor in myasthenic patients.
    Zhang Y; Schluep M; Frutiger S; Hughes GJ; Jeannet M; Steck A; Barkas T
    Eur J Immunol; 1990 Dec; 20(12):2577-83. PubMed ID: 2269325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T and B cell responses to myelin-oligodendrocyte glycoprotein in multiple sclerosis.
    Sun J; Link H; Olsson T; Xiao BG; Andersson G; Ekre HP; Linington C; Diener P
    J Immunol; 1991 Mar; 146(5):1490-5. PubMed ID: 1899688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic restriction of autoreactive acetylcholine receptor-specific T lymphocytes in myasthenia gravis.
    Hohlfeld R; Conti-Tronconi B; Kalies I; Bertrams J; Toyka KV
    J Immunol; 1985 Oct; 135(4):2393-9. PubMed ID: 2411794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of T cell subpopulations and recombinant interleukin (IL)-2 on peripheral B cell function in patients with myasthenia gravis.
    Zhang J; Zhou WB; Wang HL; Guo SS
    Hum Antibodies; 1997; 8(2):90-4. PubMed ID: 9289393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the initial trigger of myasthenia gravis and suppression of the disease by antibodies against the MHC peptide region involved in the presentation of a pathogenic T-cell epitope.
    Atassi MZ; Oshima M; Deitiker P
    Crit Rev Immunol; 2001; 21(1-3):1-27. PubMed ID: 11642597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.